Comprehensive description of adult-onset Still's disease after COVID-19 vaccination

被引：0
|
作者：
Palassin, P. [1 ]
Bres, V. [1 ]
Hassan, S. [2 ]
Alfonsi, A. [1 ]
Massy, N. [3 ]
Gras-Champel, V. [4 ]
Maria, A. T. J. [5 ,6 ]
Faillie, J. L. [7 ,8 ]
机构：
[1] CHU Montpellier, Dept Med Pharmacol & Toxicol, Montpellier, France
[2] Mende Hosp, Dept Pharm, Mende, France
[3] CHU Rouen, Dept Pharmacol, Reg Pharmacovigilance Ctr, Rouen, France
[4] CHU Amiens Picardie, Dept Clin Pharmacol, Reg Pharmacovigilance Ctr, Amiens, France
[5] Montpellier Univ Hosp, Inst Regenerat Med & Biotherapy IRMB, St Eloi Hosp, Internal Med & Immuno Oncol MEDI2O, Montpellier, France
[6] Univ Montpellier, IRMB, Montpellier, France
[7] CHU Montpellier, Dept Med Pharmacol & Toxicol, Montpellier, France
[8] Univ Montpellier, IDESP, INSERM, Montpellier, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2023年 / 37卷
关键词：
adult-onset Still's disease; adverse drug reactions; auto-inflammation; COVID-19; pharmacovigilance; vaccination;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PM1-024
引用
收藏
页码：61 / 62
页数：2
相关论文
共 50 条
  • [41] Anakinra in COVID-19 therapy: what have we learned from adult-onset Still's disease?
    Bilia, S.
    Giannini, D.
    Rizzelli, G. M. L.
    Tavoni, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (03) : 579 - 579
  • [42] Association between adult-onset still's disease and COVID-19: A report of two cases and brief review
    Fet-He, Sarah
    Lecompte, Gabriel Ibarra
    Alfaro, Alejandro Jose Quiroz
    SAGE OPEN MEDICAL CASE REPORTS, 2024, 12
  • [43] Macrophage activation syndrome in a patient with adult-onset Still's disease following first COVID-19 vaccination with BNT162b2
    Muench, Frederic
    Krusche, Martin
    Sander, Leif Erik
    Rose, Thomas
    Burmester, Gerd-Ruediger
    Schneider, Udo
    BMC RHEUMATOLOGY, 2021, 5 (01)
  • [44] Macrophage activation syndrome in a patient with adult-onset Still’s disease following first COVID-19 vaccination with BNT162b2
    Frédéric Muench
    Martin Krusche
    Leif Erik Sander
    Thomas Rose
    Gerd-Rüdiger Burmester
    Udo Schneider
    BMC Rheumatology, 5
  • [45] Adult-Onset Still's Disease: A Review
    Fong, Weng Seng
    Lui, Nai Lee
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2013, 22 (01) : 40 - 47
  • [46] Adult-onset Still's disease in pregnancy
    Yamamoto, Motohisa
    Tabeya, Tetsuya
    Suzuki, Chisako
    Naishiro, Yasuyoshi
    Yajima, Hidetaka
    Shimizu, Yui
    Obara, Mikiko
    Yamamoto, Hiroyuki
    Sugaya, Toshiaki
    Takahashi, Hiroki
    Imai, Kohzoh
    Shinomura, Yasuhisa
    MODERN RHEUMATOLOGY, 2012, 22 (01) : 163 - 165
  • [47] Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19
    Chen, Po-Ku
    Lan, Joung-Liang
    Huang, Po-Hao
    Hsu, Jye-Lin
    Chang, Ching-Kun
    Tien, Ni
    Lin, Hui-Ju
    Chen, Der-Yuan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [48] Adult-Onset Still's Disease Following COVID-19 Infection in a Patient Receiving Nirmatrelvir/Ritonavir: A Case Report
    El Hasbani, Georges
    Applewhite, Andres I.
    Scheuing, William
    Maher, Lawena
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [49] Urticaria and adult-onset Still's disease
    Plateros-Elaba, ZRM
    Santos-Ocampo, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P59 - P59
  • [50] Adult-onset Still's disease complications
    Fauter, M.
    Gerfaud-Valentin, M.
    Delplanque, M.
    Georgin-Lavialle, S.
    Seve, P.
    Jamilloux, Y.
    REVUE DE MEDECINE INTERNE, 2020, 41 (03): : 168 - 179
12345